Correction to: Nature Neuroscience https://doi.org/10.1038/s41593-018-0077-5, published online 5 February 2018.
In the version of this article initially published, the affiliation for Jian Zhang and Shuangli Mi was incomplete. In addition to the Key Laboratory of Genomics and Precision Medicine, they are also affiliated with the University of Chinese Academy of Sciences, Beijing, China. In Supplementary Fig. 1h,l, the molecular mass marker accompanying Snap25 was labeled 58 kDa; the correct value is 25 kDa. In Supplementary Fig. 9b,c, the top panel was labeled Syt1, with molecular mass markers ranging from 46 to 100 kDa; it is actually Snap25, with molecular mass markers ranging from 17 to 46 kDa. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41593-018-0077-5.
Rights and permissions
About this article
Cite this article
Zheng, Y., Shen, W., Zhang, J. et al. Author Correction: CRISPR interference-based specific and efficient gene inactivation in the brain. Nat Neurosci 21, 894 (2018). https://doi.org/10.1038/s41593-018-0125-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-018-0125-1
This article is cited by
-
CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury
Molecular Neurobiology (2020)
-
A screening method to identify efficient sgRNAs in Arabidopsis, used in conjunction with cell-specific lignin reduction
Biotechnology for Biofuels (2019)
-
CRISPRa-mediated FOXP3 gene upregulation in mammalian cells
Cell & Bioscience (2019)
